Market Research Logo

Alexza Pharmaceuticals Inc - Strategic SWOT Analysis Review

Alexza Pharmaceuticals Inc - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Alexza Pharmaceuticals Inc (Alexza), a wholly owned subsidiary of Ferrer Therapeutics Inc, focuses on the research, development and commercialization of novel, proprietary products for the treatment of acute central nervous system diseases. The company develops all its products based on its own proprietary technology, Staccato system (a hand-held inhaler), which is the foundation for Adasuve (loxapine), and all other product candidates. The company’s lead product Adasuve (Staccato loxapine) is indicated for the treatment of agitation associated with schizophrenia or bipolar I disorder. The company’s pipeline products consist of AZ-002 (Staccato alprazolam) for acute repetitive seizures and AZ-007 (Staccato zaleplon) for insomnia. Alexza is headquartered in Mountain View, California, the US.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company
Alexza Pharmaceuticals Inc - Key Facts
Alexza Pharmaceuticals Inc - Key Employees
Alexza Pharmaceuticals Inc - Key Employee Biographies
Alexza Pharmaceuticals Inc - Key Operational Employees
Alexza Pharmaceuticals Inc - Major Products and Services
Alexza Pharmaceuticals Inc - History
Alexza Pharmaceuticals Inc - Company Statement
Alexza Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Alexza Pharmaceuticals Inc - Business Description
Alexza Pharmaceuticals Inc - Corporate Strategy
Alexza Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Alexza Pharmaceuticals Inc - Strengths
Alexza Pharmaceuticals Inc - Weaknesses
Alexza Pharmaceuticals Inc - Opportunities
Alexza Pharmaceuticals Inc - Threats
Alexza Pharmaceuticals Inc - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Alexza Pharmaceuticals Inc, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Alexza Pharmaceuticals Inc, Key Facts
Alexza Pharmaceuticals Inc, Key Employees
Alexza Pharmaceuticals Inc, Key Employee Biographies
Alexza Pharmaceuticals Inc, Key Operational Employees
Alexza Pharmaceuticals Inc, Major Products and Services
Alexza Pharmaceuticals Inc, History
Alexza Pharmaceuticals Inc, Subsidiaries
Alexza Pharmaceuticals Inc, Key Competitors
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Alexza Pharmaceuticals Inc, Recent Deals Summary
List of Figures
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report